Samar Farha is a Respiratory physician affiliated with Cleveland Clinic. OpenAlex indexes 84 publications with 1,757 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Pulmonary And Critical Care Department, A90
Cleveland, OH 441950001
Telephone
216-444-4707Registry record last updated 2 Oct 2007.
Clinical trials
- Oral Iron Supplementation in Pulmonary Hypertension
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- Actelion Pharmaceuticals US, Inc.Program year20241 payment
- Inari Medical, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
29.4%Phosphodiesterase 5 Inhibitor29.4%Sildenafil Citrate64%Tadalafil36%Part D<11 patientsCardiovascular
28.8%Endothelin Receptor Antagonist16.9%Ambrisentan78%Opsumit22%Part D<11 patientsLoop diuretic7.5%Furosemide100%Part D≥12 patients+ 1 more class in this area
Blood & clotting
23.1%Prostacycline Vasodilator19.4%Tyvaso Dpi82%Orenitram Er18%Part D<11 patientsProstacyclin Receptor Agonist3.8%Uptravi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension
European Respiratory Journal
2026 - Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular Disease
Journal of the American Heart Association
2025 - Ground-Glass Opacities in Pulmonary Arterial Hypertension—Results from the PVDOMICS Study
Annals of the American Thoracic Society
2025 - Utility of inhaled nitric oxide vasoreactivity challenge in pulmonary hypertension associated with interstitial lung disease
Annals of the American Thoracic Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”